Lupin Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Lupin Inaugurates Atharv Ability, an Advanced Multidisciplinary Neuro-Rehabilitation Center in Delhi".
LUPIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lupin has launched Atharv Ability, a new neuro-rehabilitation center in Naraina Vihar, Delhi. This is the company's third such facility, following successful centers in Mumbai (2023) and Hyderabad (2024). The center provides comprehensive rehabilitation services for neurological conditions including stroke, traumatic brain injury, spinal cord injury, Parkinson's disease, multiple sclerosis, and pediatric neurological disorders. The facility features advanced technologies such as end-effector robotics for gait and hand training, AI-based balance systems, and virtual reality-based therapies. This expansion aims to address the limited availability of specialized neuro-rehabilitation services in North India.
This announcement signals Lupin's continued diversification into healthcare services beyond traditional pharma. While the immediate financial impact is minimal, it demonstrates the company's strategy to expand its healthcare ecosystem through subsidiaries like Lupin Diagnostics and Lupin Digital Health. Shareholders may view this positively as it shows ongoing investment in growth areas.